X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Part D cliff ahead

By Juliet Johnson  |    June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...   Read More

Part D cliff looms for seniors, as program stability could be in jeopardy

By Juliet Johnson  |    June 18, 2018
For more than a decade, Medicare Part D has successfully provided seniors comprehensive prescription drug coverage that meets their needs, while its market-based structure has kept overall program...   Read More

Sharing negotiated discounts at the pharmacy counter could save seniors with diabetes more than $350 annually

By Holly Campbell  |    May 17, 2018
Sharing a portion of negotiated rebates at the pharmacy counter could save seniors in Medicare with diabetes more than $350 annually, according to a new analysis from IHS Markit. The data also...   Read More

New “Let’s Talk About Medicare” campaign focuses on solutions to improve affordability and predictability for seniors in Part D

By Juliet Johnson  |    May 9, 2018
Today, we are launching the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D. Similar to how the “...   Read More

Medicare Monday: New Xcenda white paper looks at four strengths of Part B

By Nicole Longo  |    April 30, 2018
In case you missed it, a recent white paper from Xcenda took a deeper look at how Medicare Part B reimburses for physician-administered medicines and how the program has evolved over time. The...   Read More

Medicare Monday: Moran finds Part B medicine prices are stable, not a key driver of Medicare costs

By Nicole Longo  |    March 26, 2018
Earlier this year, we examined research that shows Part B spending continues to be a small, stable share of overall Medicare spending. Today, we’re looking at the trends in Average Sales Price...   Read More

ICYMI – Two PBM reports show dramatic slowdown in medicine spending growth

By Holly Campbell  |    March 2, 2018
Newly released pharmacy benefit manager (PBM) data show medicine spending is growing at the slowest rate in years. After accounting for discounts and rebates negotiated with biopharmaceutical...   Read More

Guess what? Part B drug spending remains stable share of Medicare spending

By Nicole Longo  |    January 23, 2018
Did you know that if you look at medicines in the pipeline for previously unmet medical needs, many are new and exciting immunotherapy treatments that are physician administered? That means these...   Read More

PhRMA urges CMS to share the savings with seniors

By Juliet Johnson  |    January 17, 2018
Yesterday, PhRMA submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) Request for Information (RFI) on sharing a portion of manufacturer rebates directly with...   Read More

Medicare Monday: Helping beneficiaries access vaccines

By Nicole Longo  |    December 18, 2017
Last month, we released a State of Vaccines report, as well as an update to our Medicines in Development for Vaccines report, which shared exciting information about the 264 vaccines currently in...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates